Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 302,338 |
Ending reported balance
After 2026-03-18 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-18 · Grant · Acquired 1,800 · Balance 298,338 Row 2 · 2026-03-18 · Grant · Acquired 4,000 · Balance 302,338 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 12, 2025 Filed Sep 12, 2025 12:32 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 68 | $2.91 | $197.88 |
DisclosureSEC source: 0001628280-25-041983 · wk-form4_1757680354.xml · nonDerivative · entry 8 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 288,889 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 11, 2025 Filed Sep 12, 2025 12:32 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 68 | $2.87 | $195.16 |
DisclosureSEC source: 0001628280-25-041983 · wk-form4_1757680354.xml · nonDerivative · entry 7 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 288,821 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 08, 2025 Filed Sep 12, 2025 12:32 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 68 | $3.39 | $230.52 |
DisclosureSEC source: 0001628280-25-041983 · wk-form4_1757680354.xml · nonDerivative · entry 6 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 288,753 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 07, 2025 Filed Sep 12, 2025 12:32 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 68 | $3.14 | $213.52 |
DisclosureSEC source: 0001628280-25-041983 · wk-form4_1757680354.xml · nonDerivative · entry 5 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 288,685 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 06, 2025 Filed Sep 12, 2025 12:32 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 68 | $3.34 | $227.12 |
DisclosureSEC source: 0001628280-25-041983 · wk-form4_1757680354.xml · nonDerivative · entry 4 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 288,617 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 05, 2025 Filed Sep 12, 2025 12:32 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 68 | $3.92 | $266.56 |
DisclosureSEC source: 0001628280-25-041983 · wk-form4_1757680354.xml · nonDerivative · entry 3 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 288,549 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 04, 2025 Filed Sep 12, 2025 12:32 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 68 | $4.01 | $272.68 |
DisclosureSEC source: 0001628280-25-041983 · wk-form4_1757680354.xml · nonDerivative · entry 2 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 288,481 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 01, 2025 Filed Sep 12, 2025 12:32 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 68 | $3.44 | $233.92 |
DisclosureSEC source: 0001628280-25-041983 · wk-form4_1757680354.xml · nonDerivative · entry 1 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 288,413 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 31, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 68 | $3.50 | $238.00 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 22 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,345 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 30, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 68 | $3.55 | $241.40 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 21 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,277 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 29, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 68 | $3.33 | $226.44 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 20 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,209 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 28, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 68 | $3.47 | $235.96 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 19 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,141 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 25, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 80 | $3.37 | $269.60 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 18 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,073 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 24, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 80 | $3.55 | $284.00 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 17 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,993 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 23, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 80 | $3.54 | $283.20 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 16 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,913 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 22, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 80 | $3.47 | $277.60 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 15 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,833 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 21, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 80 | $3.45 | $276.00 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 14 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,753 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 18, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 80 | $3.59 | $287.20 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 13 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,673 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 17, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 80 | $3.82 | $305.60 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 12 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,593 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 16, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 80 | $3.79 | $303.20 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 11 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,513 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 15, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 80 | $3.45 | $276.00 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 10 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,433 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 14, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 80 | $3.46 | $276.80 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 9 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,353 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 11, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 80 | $3.21 | $256.80 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 8 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,273 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 10, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 80 | $3.20 | $256.00 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 7 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,193 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 09, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 80 | $3.05 | $244.00 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 6 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,113 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 08, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 80 | $3.06 | $244.80 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 5 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,033 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 07, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 80 | $3.23 | $258.40 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 4 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 286,953 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 03, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 80 | $3.31 | $264.80 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 3 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 286,873 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 02, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 80 | $3.52 | $281.60 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 2 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 286,793 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 01, 2025 Filed Aug 11, 2025 12:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 80 | $3.56 | $284.80 |
DisclosureSEC source: 0001628280-25-039397 · wk-form4_1754915953.xml · nonDerivative · entry 1 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 286,713 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 30, 2025 Filed Jul 11, 2025 21:46 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 80 | $2.74 | $219.20 |
DisclosureSEC source: 0001628280-25-034814 · wk-form4_1752270372.xml · nonDerivative · entry 20 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,633 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 27, 2025 Filed Jul 11, 2025 21:46 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 45 | $2.60 | $117.00 |
DisclosureSEC source: 0001628280-25-034814 · wk-form4_1752270372.xml · nonDerivative · entry 19 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,553 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 26, 2025 Filed Jul 11, 2025 21:46 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 45 | $2.71 | $121.95 |
DisclosureSEC source: 0001628280-25-034814 · wk-form4_1752270372.xml · nonDerivative · entry 18 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,508 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 25, 2025 Filed Jul 11, 2025 21:46 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 45 | $3.27 | $147.15 |
DisclosureSEC source: 0001628280-25-034814 · wk-form4_1752270372.xml · nonDerivative · entry 17 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,463 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 24, 2025 Filed Jul 11, 2025 21:46 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 45 | $3.91 | $175.95 |
DisclosureSEC source: 0001628280-25-034814 · wk-form4_1752270372.xml · nonDerivative · entry 16 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,418 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 23, 2025 Filed Jul 11, 2025 21:46 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 45 | $4.61 | $207.45 |
DisclosureSEC source: 0001628280-25-034814 · wk-form4_1752270372.xml · nonDerivative · entry 15 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,373 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 20, 2025 Filed Jul 11, 2025 21:46 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 45 | $5.29 | $238.05 |
DisclosureSEC source: 0001628280-25-034814 · wk-form4_1752270372.xml · nonDerivative · entry 14 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,328 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 18, 2025 Filed Jul 11, 2025 21:46 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 45 | $5.52 | $248.40 |
DisclosureSEC source: 0001628280-25-034814 · wk-form4_1752270372.xml · nonDerivative · entry 13 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,283 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 17, 2025 Filed Jul 11, 2025 21:46 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 45 | $5.61 | $252.45 |
DisclosureSEC source: 0001628280-25-034814 · wk-form4_1752270372.xml · nonDerivative · entry 12 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,238 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 16, 2025 Filed Jul 11, 2025 21:46 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 45 | $5.32 | $239.40 |
DisclosureSEC source: 0001628280-25-034814 · wk-form4_1752270372.xml · nonDerivative · entry 11 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,193 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 13, 2025 Filed Jul 11, 2025 21:46 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 45 | $5.81 | $261.45 |
DisclosureSEC source: 0001628280-25-034814 · wk-form4_1752270372.xml · nonDerivative · entry 10 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,148 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 12, 2025 Filed Jul 11, 2025 21:46 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 45 | $5.67 | $255.15 |
DisclosureSEC source: 0001628280-25-034814 · wk-form4_1752270372.xml · nonDerivative · entry 9 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,103 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 11, 2025 Filed Jul 11, 2025 21:46 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 45 | $5.57 | $250.65 |
DisclosureSEC source: 0001628280-25-034814 · wk-form4_1752270372.xml · nonDerivative · entry 8 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,058 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 10, 2025 Filed Jul 11, 2025 21:46 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 45 | $6.00 | $270.00 |
DisclosureSEC source: 0001628280-25-034814 · wk-form4_1752270372.xml · nonDerivative · entry 7 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,013 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 09, 2025 Filed Jul 11, 2025 21:46 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 45 | $5.94 | $267.30 |
DisclosureSEC source: 0001628280-25-034814 · wk-form4_1752270372.xml · nonDerivative · entry 6 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 285,968 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 06, 2025 Filed Jul 11, 2025 21:46 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 45 | $5.57 | $250.65 |
DisclosureSEC source: 0001628280-25-034814 · wk-form4_1752270372.xml · nonDerivative · entry 5 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 285,923 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 05, 2025 Filed Jul 11, 2025 21:46 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 45 | $5.46 | $245.70 |
DisclosureSEC source: 0001628280-25-034814 · wk-form4_1752270372.xml · nonDerivative · entry 4 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 285,878 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 04, 2025 Filed Jul 11, 2025 21:46 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 45 | $5.75 | $258.75 |
DisclosureSEC source: 0001628280-25-034814 · wk-form4_1752270372.xml · nonDerivative · entry 3 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 285,833 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 03, 2025 Filed Jul 11, 2025 21:46 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 45 | $5.61 | $252.45 |
DisclosureSEC source: 0001628280-25-034814 · wk-form4_1752270372.xml · nonDerivative · entry 2 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 285,788 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 02, 2025 Filed Jul 11, 2025 21:46 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 45 | $5.20 | $234.00 |
DisclosureSEC source: 0001628280-25-034814 · wk-form4_1752270372.xml · nonDerivative · entry 1 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 285,743 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.